Trevogrumab

Trevogrumab (REGN-1033) is a monoclonal antibody targeting GDF8 (growth differentiation factor 8, also known as muscle growth inhibitor). Trevogrumab is used in studies of sarcopenia, including wasting atrophy, chronic diseases, and changes in food and nutritional intake.
Read more
€0.00 (tax incl.)
Reference:
HY-P99388
Product Details
HY-P99388

Data sheet

Size
Multiple sizes
Reactivity
Others
Application
Metabolism-protein/nucleotide metabolism
CAS
1429201-24-0

Menu

Settings